Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUB-040 in Combination With Standard Ovarian Cancer Drugs in Advanced Ovarian Cancer
NCT07736937Phase 2Recruiting
- Sponsor
- Tubulis
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Countries
- 3
01
Overview
A Phase 2 trial of TUB-040 in ovarian cancer, sponsored by Tubulis. Started Mar 2026; status: recruiting.
02
Drugs
TUB-040
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT07736937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07736937.